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ABSTRACT 
Aims: To examine the association between UCP1, UCP2 and UCP3 gene 
polymorphisms with adiposity markers in European adolescents, and to test if there 
were gene interactions with objectively measured physical activity and adiposity.  
Methods: A cross-sectional study that involves 1.057 European adolescents (12-18 
years old) from the Healthy Lifestyle in Europe by Nutrition in Adolescence Cross-
Sectional Study. A total of 18 polymorphisms in UCP1, UCP2 and UCP3 genes were 
genotyped. We measured weight, height, waist and hip circumferences and triceps and 
subscapular skinfold thickness. Physical activity was objectively measured by 
accelerometry during 7 days. 
Results: The C allele of the UCP1 rs6536991 polymorphism was associated with a 
lower risk of overweight [odds ratio (OR): T/C + C/C vs. T/T) = 0.72; 95% confidence 
interval (CI): 0.53 to 0.98; P=0.034; false discovery rate (FDR)=0.048)]. There was a 
significant interaction between UCP1 rs2071415 polymorphism and physical activity 
with waist-to-hip ratio (P = 0.006; FDR = 0.026). Adolescents who did not meet the 
physical activity recommendations (less than 60min/day of moderate to vigorous 
physical activity) and carrying the C/C genotype had higher waist-to-hip ratio (+ 0.067; 
95% CI, 0.028 to 0.106; P = 0.003), while no differences across genotypes were 
observed in adolescents meeting the recommendations.  
Conclusions: Two UCP1 polymorphisms were associated with adiposity in European 
adolescents. Meeting the daily physical activity recommendations may overcome the 
effect of the UCP1 rs2071415 polymorphism on obesity-related traits.  
 
Keywords: Physical Activity, Brown Adipose Tissue, Genetic Susceptibility, 
Adolescents, Uncoupling Protein  
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INTRODUCTION 
Obesity is a major public health problem throughout the world. Despite later reports 
suggest a plateau in children's and adolescent’s body mass index (BMI) from high-
income countries, there are still little evidences on strategies to stop this pandemic1. 
Obesity is a result of a complex interaction between environmental and genetic 
factors2. Several studies showed that physical activity may overcome the effect of 
several gene polymorphisms on obesity-related traits. A genome-wide meta-analysis of 
200,452 European adults showed that physical activity may attenuate the deleterious 
effect of the FTO (fat mass- and obesity-associated) gene polymorphisms on obesity3. 
In adolescents, we showed that meeting the daily physical activity recommendations 
(at least 60 minutes/day of moderate to vigorous physical activity) may offset the 
genetic predisposition to obesity associated with the FTO rs9939609 polymorphism in 
European adolescents4.  
The strong genetic influence in obesity has been described as a non-mendelian 
way of inheritance. Only few percent of cases are monogenic obesity type. In these 
cases, monogenic obesity genes are involved in the control of appetite center and satiety 
like leptin (LEP), leptin receptor (LEPR), pro-opiomelacortin (POMC) or 
prohormoneconvertase 1 (PCSK1) 5. However, 95% of the cases of obesity can be 
explained by genetic variants of multiple genes and complex gene-gene and gene-
lifestyle interactions 2,6,7, among which are uncoupling proteins (UCPs) gene 
polymorphisms 8. 
The most known UCP genes include UCP1, UCP2 and UCP3. UCP1 is 
responsible of heat production through non-shivering thermogenesis in brown adipose 
tissue (BAT) 9. Less clear is, however, the role of UCP2 and UCP3 genetic variants, 
which have been related with obesity phenotypes through the potential influence on 
 6 
muscle metabolism due to the high expression of these genes in skeletal muscle 10, 
diabetes mellitus and lipid/ lipoprotein-related diseases 11. UCP2 seems to be involved 
in the control of reactive oxygen species (ROS) production, a modulator of insulin 
secretion and a regulator of mitochondrial fatty acid oxidation12. More recently, Caron 
et al.13 reported that UCP2 may have a regulating role in thermogenesis of BAT. UCP3 
role relates with the coupling regulation of mitochondrial respiration in skeletal muscle 
mitochondria14 and as mediator of thermogenesis15. The UCP1 rs6536991 
polymorphism16, UCP2 rs65936617, rs660339 polymorphisms18–21 and UCP3 
rs1800849, rs2075577 polymorphisms21,22 have been associated with obesity traits, but 
most of them have been studied in adults and the results are so far controversial. Several 
studies suggested that the rs659366-A allele (UCP-2) might be protective against 
obesity in 55 age average subjects17, whereas others found an association of the 
rs659366-A allele with a borderline increase of fat body mass index (FBMI) 19 and 
higher risk of central obesity20.  
Data obtained within the Healthy Lifestyle in Europe by Nutrition in 
Adolescence (HELENA) study provide an excellent opportunity to study the 
association between UCP1, UCP2 and UCP3 gene polymorphisms with adiposity 
makers in European adolescents. The HELENA study was designed to provide reliable 
data on nutrition and health-related variables in a relatively large sample of European 
adolescents from 9 different countries and includes information on 18 polymorphisms 
(SNPs) of the UCP1, UCP2 and UCP3 genes as well as markers of adiposity. To our 
knowledge, UCP polymorphisms have not been identified in GWAS of body weight or 
body composition in adults or other age groups.  
The aim of this study was therefore to examine the association between 18 
UCP1, UCP2 and UCP3 polymorphisms with total and central adiposity markers in 
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European adolescents, and to test if there were gene x physical activity interactions on 
adiposity phenotypes.  
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Material and methods 
Participants 
Adolescents were part of the Healthy Lifestyle in Europe by Nutrition in Adolescence 
(HELENA) cross-sectional study. A total of 3865 adolescents (12-18 year old) of 10 
centers in nine European countries were recruited between 2006 and 2007. Adolescents 
were randomly selected from schools by using a proportional cluster sampling method, 
and age was taken into account. One-third of the classes were randomly selected for 
blood collection, resulting in a total of 1155 blood samples for the subsequent clinical 
biochemistry assays and genetic analyses. Among these participants, 1057 individuals 
(552 girls) with data on UCP1, UCP2 and UCP3 gene polymorphisms, adiposity 
phenotypes and physical activity were included in this study. After receiving complete 
information about the aims and methods of the study, all adolescents and their parents 
or guardians signed an informed written consent. All participants met the general 
HELENA inclusion criteria23. The study was performed following the ethical 
guidelines of the Declaration of Helsinki 1961 (revision of Edinburgh 2000), Good 
Clinical Practice, and legislation about clinical research in humans in each of the 
participating countries. The corresponding local human research review committees of 
the involved centers approved the protocol.  
 
Assessment of adiposity 
Weight and height were measured following standard methods. Waist and hip 
circumference was measured in triplicate with an anthropometric unelastic tape (SECA 
200; Seca Deutschland, Hamburg, Germany) and was used as a surrogate measure of 
central body fat. We calculated waist to height and waist to hip ratios. BMI was 
calculated as weight in kilograms divided by height in meters squared. Adolescents 
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were classified according to BMI (kg/m2) as normal weight, overweight or obese 
categories according to Cole et al.24. The overweight-obese categories were grouped 
into one category (hereafter called overweight). Skinfold thickness was measured to the 
nearest 0.2 mm in triplicate on the left side at the biceps, triceps, subscapularis, 
suprailium, thigh, and medial calf with a Holtain Caliper (Holtain Ltd, Crymmych, 
Wales). Body fat percentage was calculated from skinfold thicknesses (triceps and 
subscapular) using the equations by Slaughter et al.25. Finally, fat mass index (FMI) 
was calculated as fat mass in kilograms divided by height in meters squared.  
  
Assessment of physical activity 
Physical activity was assessed during 7 consecutive days with a uniaxial accelerometer 
(GT1M; ActiGraph, Pensacola, Florida) attached to the lower back26 . Adolescents were 
instructed to wear the accelerometer during all time awake and to remove it only during 
water-based activities. At least 3 days of recording with a minimum of 8 hours 
registered per day was set as an inclusion criterion26. The time-sampling interval 
(epoch) was set at 15 seconds. We calculated the time engaged in at least moderate 
physical activity (≥3 metabolic equivalents) based on a standardized cutoff of 2000 
counts/min or more. Moderate to vigorous physical activity was dichotomized into less 
than 60 min/day and 60 min/day or longer26. 
 
Genotyping 
The genotyping was done by an Illumina system (Illumina, Inc, San Diego, California) 
using the GoldenGate technology (GoldenGate Software, Inc, San Francisco, 
California). The mean genotyping success rate was 99.84%. All genotype distributions 
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respected Hardy-Weinberg equilibrium (P > 0.2; Appendix S1). Some polymorphisms 
exhibited linkage disequilibrium between them (Appendix S2, S3).  
 
Data analysis 
Deviations from Hardy-Weinberg equilibrium were assessed by means of an exact test 
and considering a P value of 0.05 as a threshold. Linkage disequilibrium between 
polymorphisms was evaluated with “genetics” R package. Associations between SNPs 
and phenotypes were analyzed by means of general linear models (GLM) using 
Gaussian and Binomial error distributions for continuous and discrete phenotypes, 
respectively. Interactions between SNPs of different UCP genes were assessed using 
the same models but including an interaction term for each gene pair. Interaction with 
physical activity was assessed for SNPs that were significantly associated with obesity 
phenotypes including an interaction term with both factors. Moreover, we performed 
the analyses stratified by moderate to vigorous physical activity categories (<60 and 
≥60 min/day). Five genetic models (dominant recessive, log-additive, codominant and 
over dominant and additive) were used for all analyses except in those that rs2071416, 
rs2735572 and rs17132534 were involved. These polymorphisms were analyzed using 
only dominant model due to the low number of minor homozygotes (MAF < 0.1; 
Appendix S1). Previous studies highlighted the association between non-additive 
models with UCPs, which indicates the importance of perform this five models and 
compare the additive models with non-additives ones 27. In all analyses, adjustment 
variables were age, gender and center. For each polymorphism, P values were 
computed using the likelihood ratio test (LRT) between a model with the polymorphism 
or interaction term and a null model without it.  
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With the purpose of controlling the chance of any false positives, we corrected the 
significance level of 0.05 by the number of test (polymorphisms) for each genetic model 
(Bonferroni correction). Therefore, significance threshold was 0.0033 for all models 
except for dominant model, in which it was 0.0028. Given that some of studied SNPs 
were in linkage disequilibrium (Appendix S2, S3), the number of independent test 
would be lower than number of studied polymorphisms and thus Bonferroni correction 
could be potentially over conservative28. Because of this, we also used a less stringent 
approach, which controls the expected proportion of false positives (False Discovery 
Rate [FDR]). As in the case of Bonferroni, the family test included all genotyped 
markers for a given genetic model (18 tests). Significance for the interaction analyses 
was determined in the same way, i.e. a family test included the interaction between 
physical activity and the 18 genotyped markers under a given heritage model. All 
analyses were performed using the “SNPassoc” package in the R environment 3.4.1.   
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Results 
Characteristics of the study sample are shown in Table 1.  
 
Association between UCP polymorphisms and markers of adiposity 
Only one of the 18 studied polymorphisms was individually associated with overweight 
phenotypes after multiple-comparison corrections (Appendix S1 & Fig. 1; Appendix 
S4:S11). The minor C allele of the UCP1 rs6536991 polymorphism was associated 
with a lower risk of overweight [odds ratio (OR): T/C + C/C vs. T/T = 0.72; 95% 
confidence interval (CI), 0.53 to 0.98; P=0.034; FDR=0.048; Figure 1). The UCP1 
rs6536991 polymorphism was not however nominally associated with BMI (Appendix 
S5) or body fat percentage (Appendix S10). We found no significant gene-gene 
interactions, whereas there was an interaction of physical activity with UCP1 
rs2071415 and UCP3 rs2075577 polymorphisms on waist to hip ratio under 
codominant model (P<0.0001; FDR=0.004, Appendix S12). However, the number of 
individuals in the interaction group were rather low. 
 
Interaction between UCP polymorphisms, physical activity and markers of adiposity 
There was a significant interaction between physical activity and the UCP1 rs2071415 
polymorphism on waist to hip ratio (P=0.006; FDR=0.026; Figure 2). The C/C 
genotype was associated with higher waist to hip ratio (+ 0.067; 95%CI, 0.028 to 0.106; 
P = 0.003) in adolescents who spent less than 60 min/day of moderate to vigorous 
physical activity (n = 399). On the contrary, the C/C genotype of the UCP1 rs2071415 
polymorphism was not associated with higher waist to hip ratio (– 0.047; 95%CI, -
0.099 to 0.004; P = 0.084) in adolescents who spent at least 60 min/day of moderate to 
vigorous physical activity (n = 290).  
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Discussion 
The results of the present study show that the C allele of the UCP1 rs6536991 
polymorphism was associated with a lower risk of overweight and obesity (OR=0.72) 
in European adolescents from 9 countries. We also observed an interaction between 
physical activity and the UCP1rs2071415 polymorphism on waist to hip ratio. 
Adolescents meeting the daily physical activity recommendations may overcome the 
effect of the UCP1 rs2071415 polymorphism on waist to hip ratio. Our results of UCP1 
polymorphisms are in agreement with others16. Ramos et al.16 showed a significant 
association between the UCP1 rs6536991 polymorphism and obesity and BMI in 352 
Brazilian adults. They showed that the C allele was associated with a lower risk of 
obesity (OR=0.69) and a lower BMI in individuals with no obesity. 
We did not find significant associations between UCP2 or UCP3 
polymorphisms and adiposity markers, which is in contrast with the finding by Van 
Abeelen et al.22 in Dutch men (40-80 years old). They reported a significant association 
between homozygosity for the minor allele (C) of UCP3 rs2075577 polymorphism and 
BMI but not with other adiposity phenotypes such as waist to hip ratio. Another study21 
reported a significant association between the (UCP3 rs2075577–UCP2 rs660339) 
haplotype with BMI. The frequency of the C–T haplotype in patients with obesity was 
significantly higher than that seen in subjects without it. However, these results were 
observed in females only. These association discordances between polymorphism and 
phenotypes may be due to the fact that they are population dependent, with possibly 
different allele frequencies and penetrance in these populations. Also differences in age, 
inter-country differences in lifestyle behaviours and sample sizes are important.  
A plausible explanation of the observed associations between polymorphisms in the 
UCP1 gene and obesity phenotypes could be because this polymorphism may lead to 
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less functional UCPs proteins. As a result, uncoupling activity could be decreased and 
therefore reduce heat dissipation as well as lipid oxidation9, leading to 
overweight/obesity. Recent studies have described that calcium cycling in the skeletal 
muscle has a similar role than UCP1 in non-shivering thermogenesis in muscle and 
BAT of rabbits 29. Indeed uncoupling ATP hydrolysis in sarcoplasmic/endoplasmic 
reticulum calcium ATPase (SERCA) mediated by sarcolipin in mice with 
overexpression of this small transmembrane proteolipid increased basal metabolic rate 
and decreased diet-induced obesity risk 30. In line with this findings, overexpression of 
UCP2 was associated with an improved fatty acid oxidation 31 suggesting a possible 
relevant role on the muscle function because UCP2 and UCP3 genes are highly 
expressed in skeletal muscle10. More studies are needed to understand if sarcolipin 
could compensate a functional deficit of UCP1 in overweight individuals such as fatty 
acid utilization by UCP2. 
Findings from our study should be taken with caution owing to its cross-sectional 
nature. Lifestyle intervention studies in adolescents are needed to determine to what 
extent the effect of UCP genes on obesity-related traits can be modified, especially in 
genetically predisposed individuals. Results about gene-gene interaction between 
UCP1 and UCP3 polymorphisms must be taken with caution due to low number of 
individuals in the interaction group with significant differences, and should be 
confirmed in other studies with larger sample sizes. Unfortunately, we have no 
information on relatedness patterns among the participants, and we do not know the 
ethnic/racial make-up of the sample.  
In conclusion, we observed an association between the UCP1 rs6536991 
polymorphism and the risk of overweight in adolescents. Our results also suggest that 
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physical activity could compensate the deleterious effect of the UCP1 rs2071415 
polymorphism on adiposity markers.  
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